Sofia Zetterstrand

888 total citations
14 papers, 657 citations indexed

About

Sofia Zetterstrand is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Sofia Zetterstrand has authored 14 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Physiology. Recurrent topics in Sofia Zetterstrand's work include Gastroesophageal reflux and treatments (3 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers) and Respiratory and Cough-Related Research (3 papers). Sofia Zetterstrand is often cited by papers focused on Gastroesophageal reflux and treatments (3 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers) and Respiratory and Cough-Related Research (3 papers). Sofia Zetterstrand collaborates with scholars based in Sweden, Canada and United Kingdom. Sofia Zetterstrand's co-authors include Hertzel C. Gerstein, Karl Swedberg, Salim Yusuf, John J.V. McMurray, Christopher B. Granger, Eric L. Michelson, Marc A. Pfeffer, Bertil Olofsson, Scott D. Solomon and Colette E. Jackson and has published in prestigious journals such as The Lancet, JAMA and Diabetes Care.

In The Last Decade

Sofia Zetterstrand

14 papers receiving 639 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sofia Zetterstrand Sweden 11 272 221 145 113 100 14 657
Ewa Król Poland 15 175 0.6× 84 0.4× 55 0.4× 190 1.7× 92 0.9× 61 587
Edward Ramadan Israel 11 105 0.4× 70 0.3× 70 0.5× 269 2.4× 185 1.9× 16 675
Konika Sharma United States 16 185 0.7× 77 0.3× 76 0.5× 141 1.2× 156 1.6× 27 619
M. Fysekidis France 15 51 0.2× 135 0.6× 145 1.0× 59 0.5× 236 2.4× 46 654
Antonio Pio Tortorelli Italy 16 65 0.2× 248 1.1× 239 1.6× 138 1.2× 379 3.8× 50 869
Cezar Macarie Romania 16 747 2.7× 208 0.9× 56 0.4× 42 0.4× 142 1.4× 30 1.0k
Kyu-Hyung Ryu South Korea 19 838 3.1× 191 0.9× 120 0.8× 36 0.3× 209 2.1× 65 1.2k
Nikki Earle New Zealand 13 803 3.0× 164 0.7× 70 0.5× 76 0.7× 87 0.9× 31 961
Denis S. Semama France 13 89 0.3× 185 0.8× 33 0.2× 76 0.7× 104 1.0× 36 553
Fabio Bioletto Italy 13 51 0.2× 79 0.4× 89 0.6× 34 0.3× 197 2.0× 66 531

Countries citing papers authored by Sofia Zetterstrand

Since Specialization
Citations

This map shows the geographic impact of Sofia Zetterstrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofia Zetterstrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofia Zetterstrand more than expected).

Fields of papers citing papers by Sofia Zetterstrand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofia Zetterstrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofia Zetterstrand. The network helps show where Sofia Zetterstrand may publish in the future.

Co-authorship network of co-authors of Sofia Zetterstrand

This figure shows the co-authorship network connecting the top 25 collaborators of Sofia Zetterstrand. A scholar is included among the top collaborators of Sofia Zetterstrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofia Zetterstrand. Sofia Zetterstrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Danese, Silvio, et al.. (2023). Long-term safety of brazikumab in the open-label period of a randomized phase 2a study of patients with Crohn’s disease. BMC Gastroenterology. 23(1). 451–451. 11 indexed citations
2.
Wise, Robert A., Kenneth R. Chapman, Benjamin M. Scirica, et al.. (2019). Effect of Aclidinium Bromide on Major Cardiovascular Events and Exacerbations in High-Risk Patients With Chronic Obstructive Pulmonary Disease. JAMA. 321(17). 1693–1693. 18 indexed citations
3.
Martínez, Fernando J., Klaus F. Rabe, Peter M.A. Calverley, et al.. (2018). Determinants of Response to Roflumilast in Severe Chronic Obstructive Pulmonary Disease: Pooled Analysis of Two Randomized Trials. American Journal of Respiratory and Critical Care Medicine. 198(10). 1268–1278. 54 indexed citations
4.
Martínez, Fernando J., Klaus F. Rabe, Sanjay Sethi, et al.. (2016). Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting β2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE2SPOND): A Randomized Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 194(5). 559–567. 93 indexed citations
5.
Krarup, Anne Lund, Lars Ny, Frederik Hvid‐Jensen, et al.. (2013). Randomized clinical trial: inhibition of the TRPV1 system in patients with nonerosive gastroesophageal reflux disease and a partial response to PPI treatment is not associated with analgesia to esophageal experimental pain. Scandinavian Journal of Gastroenterology. 48(3). 274–284. 102 indexed citations
6.
7.
Zetterstrand, Sofia, et al.. (2010). Long-Term Outcome after Treatment of Hydrocephalus in Children. Pediatric Neurosurgery. 46(3). 221–226. 33 indexed citations
8.
9.
Svensson, Maria, et al.. (2010). Reversible elevations of serum creatinine levels but no effect on glomerular filtration during treatment with the direct thrombin inhibitor AZD0837. European Journal of Clinical Pharmacology. 66(9). 903–910. 12 indexed citations
10.
Labenz, Joachim, David Armstrong, Sofia Zetterstrand, Stefan Eklund, & Andreas Leodolter. (2009). Clinical trial: factors associated with resolution of heartburn in patients with reflux oesophagitis – results from the EXPO study. Alimentary Pharmacology & Therapeutics. 29(9). 959–966. 7 indexed citations
11.
Labenz, Joachim, David Armstrong, Sofia Zetterstrand, Stefan Eklund, & Andreas Leodolter. (2009). Clinical trial: factors associated with freedom from relapse of heartburn in patients with healed reflux oesophagitis ‐ results from the maintenance phase of the EXPO study. Alimentary Pharmacology & Therapeutics. 29(11). 1165–1171. 9 indexed citations
12.
Jackson, Colette E., Scott D. Solomon, Hertzel C. Gerstein, et al.. (2009). Albuminuria in chronic heart failure: prevalence and prognostic importance. The Lancet. 374(9689). 543–550. 224 indexed citations
13.
Karlson, Björn W., Sofia Zetterstrand, Bertil Olofsson, & Dag Elmfeldt. (2009). A dose-response analysis of candesartan-hydrochlorothiazide combination therapy in patients with hypertension. Blood Pressure. 18(3). 149–156. 12 indexed citations
14.
Preiss, David, Sofia Zetterstrand, John J.V. McMurray, et al.. (2009). Predictors of Development of Diabetes in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Diabetes Care. 32(5). 915–920. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ewa Król Breakdown of academic impact, for papers by Edward Ramadan Breakdown of academic impact, for papers by Konika Sharma Breakdown of academic impact, for papers by M. Fysekidis Breakdown of academic impact, for papers by Antonio Pio Tortorelli Breakdown of academic impact, for papers by Cezar Macarie Breakdown of academic impact, for papers by Kyu-Hyung Ryu Breakdown of academic impact, for papers by Nikki Earle Breakdown of academic impact, for papers by Denis S. Semama Breakdown of academic impact, for papers by Fabio Bioletto
Rankless by CCL
2026